NFKB1 and chronic rhinosinusitis with nasal polyps: In the latest study, Jiang et al[193] discovered that NF-κB inhibitors and p38 MAPK inhibitors can effectively reduce the expression of TNF-α and IL-6 mRNA in nasal epithelial cells of patients with CRSwNP.